These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 36582006)

  • 1. (De)Prescribing of proton pump inhibitors: what has changed in recent years? an observational regional study from the French health insurance database.
    Gendre P; Mocquard J; Artarit P; Chaslerie A; Caillet P; Huon JF
    BMC Prim Care; 2022 Dec; 23(1):341. PubMed ID: 36582006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inappropriate proton-pump inhibitor prescribing in primary care - an observational study with quality circles.
    Vidonscky Lüthold R; Henz NC; Fuhrer C; Häner A; Schenk M; Jungo KT; Streit S
    Swiss Med Wkly; 2023 Sep; 153():40119. PubMed ID: 37769322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of a multi-faceted intervention to deprescribe proton pump inhibitors in primary care: protocol for a population-based, pragmatic, cluster-randomized controlled trial.
    Nguyen-Soenen J; Rat C; Gaultier A; Schirr-Bonnans S; Tessier P; Fournier JP
    BMC Health Serv Res; 2022 Feb; 22(1):219. PubMed ID: 35177042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is there overuse of proton pump inhibitors in B-cell non-Hodgkin lymphomas? A cohort study based on the French health insurance database in the Midi-Pyrénées region.
    Conte C; Bourrel R; Despas F; Lapeyre-Mestre M
    Fundam Clin Pharmacol; 2019 Jun; 33(3):327-338. PubMed ID: 30625254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prescribing, deprescribing and potential adverse effects of proton pump inhibitors in older patients with multimorbidity: an observational study.
    Aubert CE; Blum MR; Gastens V; Dalleur O; Vaillant F; Jennings E; Aujesky D; Thompson W; Kool T; Kramers C; Knol W; O'Mahony D; Rodondi N
    CMAJ Open; 2023; 11(1):E170-E178. PubMed ID: 36854455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of a Proton Pump Inhibitor Deprescribing Guideline on Drug Usage and Costs in Long-Term Care.
    Thompson W; Hogel M; Li Y; Thavorn K; O'Donnell D; McCarthy L; Dolovich L; Black C; Farrell B
    J Am Med Dir Assoc; 2016 Jul; 17(7):673.e1-4. PubMed ID: 27289201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and Implementation of a Pharmacist-Led Proton Pump Inhibitor Deprescribing Algorithm in a Geriatric Ambulatory Office.
    Leszcynski L; Bente J
    Sr Care Pharm; 2023 Mar; 38(3):105-112. PubMed ID: 36803698
    [No Abstract]   [Full Text] [Related]  

  • 8. Proton pump inhibitors prescriptions in France: Main trends from 2006 to 2016 on French health insurance database.
    Boucherie Q; Rouby F; Frankel D; Roll P; Micallef J
    Therapie; 2018 Oct; 73(5):385-388. PubMed ID: 29778306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proton pump inhibitor utilisation and potentially inappropriate prescribing analysis: insights from a single-centred retrospective study.
    Liu Y; Zhu X; Li R; Zhang J; Zhang F
    BMJ Open; 2020 Nov; 10(11):e040473. PubMed ID: 33243802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determining proton pump inhibitor prescription dispensing patterns and adherence to STOPP criteria for Nova Scotia Seniors Pharmacare Program beneficiaries.
    Carter JH; Sketris IS; Tamim H; Levy AR; Langley JM
    J Popul Ther Clin Pharmacol; 2019 Dec; 26(4):e37-e53. PubMed ID: 31909577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inappropriate prescribing of proton pump inhibitors in older patients: effects of an educational strategy.
    Hamzat H; Sun H; Ford JC; Macleod J; Soiza RL; Mangoni AA
    Drugs Aging; 2012 Aug; 29(8):681-90. PubMed ID: 22775478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of proton pump inhibitors in adults in France: a nationwide drug utilization study.
    Lassalle M; Le Tri T; Bardou M; Biour M; Kirchgesner J; Rouby F; Dumarcet N; Zureik M; Dray-Spira R
    Eur J Clin Pharmacol; 2020 Mar; 76(3):449-457. PubMed ID: 31838548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Feasibility of a patient-centered deprescribing process to reduce inappropriate use of proton pump inhibitors.
    Reeve E; Andrews JM; Wiese MD; Hendrix I; Roberts MS; Shakib S
    Ann Pharmacother; 2015 Jan; 49(1):29-38. PubMed ID: 25385826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of NPS MedicineWise general practitioner education programs and Choosing Wisely Australia recommendations on prescribing of proton pump inhibitors in Australia.
    Wu J; Dickinson S; Elgebaly Z; Blogg S; Heaney A; Soo Y; Daniels B; Weekes L
    BMC Fam Pract; 2020 May; 21(1):85. PubMed ID: 32386520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opportunities for successful de-escalation of proton pump inhibitors at a federally qualified health center.
    Ayoub J; McGregor JC; Castner RM; Singh H
    BMC Pharmacol Toxicol; 2021 Apr; 22(1):20. PubMed ID: 33863393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of consumer information leaflets for deprescribing in older hospital inpatients: a mixed-methods study.
    Jokanovic N; Aslani P; Carter S; Duong M; Gnjidic D; Jansen J; Le Couteur D; Hilmer S
    BMJ Open; 2019 Dec; 9(12):e033303. PubMed ID: 31831548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. We have had a gutful: The need for deprescribing proton pump inhibitors.
    Naunton M; Peterson GM; Deeks LS; Young H; Kosari S
    J Clin Pharm Ther; 2018 Feb; 43(1):65-72. PubMed ID: 28895169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prescribing Portraits to Optimize Prescribing of Proton Pump Inhibitors in Long-Term Care: PPI-T STOP Study.
    Wang Y; Spence L; Tung A; Bubbar CD; Thompson W; Tejani AM
    Can J Hosp Pharm; 2024; 77(1):e3461. PubMed ID: 38482392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Encouraging appropriate use of proton pump inhibitors: existing initiatives and proposals for the future.
    Mari A; Marabotto E; Ribolsi M; Zingone F; Barberio B; Savarino V; Savarino EV
    Expert Rev Clin Pharmacol; 2023; 16(10):913-923. PubMed ID: 37632213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of Interventions to Deprescribe Inappropriate Proton Pump Inhibitors in Older Adults.
    Wilsdon TD; Hendrix I; Thynne TR; Mangoni AA
    Drugs Aging; 2017 Apr; 34(4):265-287. PubMed ID: 28220380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.